Gossamer launches risky IPO despite US shutdown

Note: This section contains information in English only.
Source: Dukascopy Bank SA
The biotech start-up Gossamer is set to launch a risky initial public offering, despite the US government shutdown, which froze stock market debuts, the company stated on Wednesday.

Actual Topics